Researchers Examine Access To GeneXpert TB Test In High-Burden Countries

Center for Global Health Policy’s “Science Speaks”: Survey shows Xpert TB diagnosis costly, out of reach in countries where private care predominates
Rabita Aziz, policy research coordinator for the Center for Global Health Policy, highlights a correspondence published in The Lancet Global Health’s February issue discussing access to the GeneXpert MTB/RIF diagnostic test for drug-resistant tuberculosis in high-burden countries…” (1/27).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.